8-K: Know Labs Enters $5 Million Capital on Demand Sales Agreement with JonesTrading

Know Labs has secured a Capital on Demand Sales Agreement with JonesTrading, allowing them to potentially sell up to $5 million of common stock.

Summary

• Know Labs, Inc. has entered into a Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC.
• Under this agreement, Know Labs may offer and sell shares of its common stock from time to time through JonesTrading.
• The company can sell up to a maximum of $5,000,000 worth of shares.
• JonesTrading will act as a sales agent and may sell shares at prevailing market prices or as otherwise agreed.
• JonesTrading will receive a commission of up to 3.0% of the gross proceeds from any shares sold.
• Know Labs is not obligated to sell any shares, and JonesTrading is not obligated to buy or sell any shares.
• The offering will be made under an existing shelf registration statement filed with the SEC.

Sentiment

Score: 6

Explanation: The document is neutral to slightly positive. It outlines a standard financial transaction that provides the company with flexibility, but also carries risks of dilution and market volatility.

Positives

• The agreement provides Know Labs with a flexible way to raise capital as needed.
• The company is not obligated to sell shares, giving them control over the timing and amount of any sales.
• The use of an existing shelf registration statement simplifies the process of selling shares.

Negatives

• The company will incur a commission of up to 3.0% on any shares sold, reducing the net proceeds.
• The agreement does not guarantee that any shares will be sold.
• The sale of shares could dilute existing shareholders' ownership.

Risks

• The company may not be able to sell all $5 million of shares if market conditions are unfavorable.
• The sale of shares could put downward pressure on the company's stock price.
• The company's reliance on this type of financing may indicate a lack of other funding options.

Future Outlook

The company may offer and sell shares of its common stock from time to time through JonesTrading, subject to market conditions and the company's needs.

Industry Context

At-the-market offerings are a common way for companies to raise capital, particularly for those with existing shelf registrations. This allows for flexibility in timing and amount of capital raised.

Comparison to Industry Standards

• The 3% commission is within the typical range for at-the-market offerings.
• The $5 million offering size is relatively small, suggesting the company may be seeking to raise capital without significant dilution.
• Other companies in the biotech and medical device space have used similar at-the-market offerings to fund operations and research.

Stakeholder Impact

• Shareholders may experience dilution if the company sells a significant number of shares.
• The company will have access to additional capital to fund its operations.
• The agreement may impact the company's stock price depending on market reaction to the announcement and subsequent sales.

Next Steps

• Know Labs may begin selling shares through JonesTrading at its discretion.
• The company will need to monitor market conditions and its capital needs to determine the timing and amount of any sales.
• JonesTrading will act as sales agent and will execute sales as instructed by Know Labs.

Key Dates

Keywords

Capital Raise, At-the-market offering, Sales Agreement, Common Stock, JonesTrading, Shelf Registration, Equity Financing, Know Labs